Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A.D.A.M. (Advanced Digital Additive Manufacturing) is a medical technology company focused on the development of 3D-printed bone implants. The company utilizes a proprietary 3D bioprinting platform to create personalized, bioresorbable scaffolds made from bioceramics and modified polymers. These implants are designed to facilitate natural bone regeneration, offering an alternative to traditional autografts and allografts. A.D.A.M.'s digital platform integrates medical imaging with automated manufacturing to provide point-of-care solutions for orthopedic and craniofacial surgeries. The company aims to reduce surgery times and improve patient outcomes through its on-demand manufacturing model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A.D.A.M. Innovations.